N-Methylbutylamine → HCID 21913048, 화합물

HRID 1352641노트

반응식

HRID 1352641 반응식
CC1N2N=NN=C2C2N=C(CCC)N(CCCS(C3C=CC(C(Cl)=O)=CC=3)(=O)=O)C=2C=1C.CNCCCC.N1CCOCC1.[CH2:45]([N:49]([CH3:81])[C:50](=[O:80])[C:51]1[CH:56]=[CH:55][C:54]([S:57]([CH2:60][CH2:61][CH2:62][N:63]2[C:71]3[C:70]([CH3:72])=[C:69]([CH3:73])[N:68]4N=N[N:76]=[C:67]4[C:66]=3[N:65]=[C:64]2[CH2:77][CH2:78][CH3:79])(=[O:59])=[O:58])=[CH:53][CH:52]=1)[CH2:46][CH2:47][CH3:48]>ClCCl>[NH2:76][C:67]1[C:66]2[N:65]=[C:64]([CH2:77][CH2:78][CH3:79])[N:63]([CH2:62][CH2:61][CH2:60][S:57]([C:54]3[CH:55]=[CH:56][C:51]([C:50]([N:49]([CH2:45][CH2:46][CH2:47][CH3:48])[CH3:81])=[O:80])=[CH:52][CH:53]=3)(=[O:59])=[O:58])[C:71]=2[C:70]([CH3:72])=[C:69]([CH3:73])[N:68]=1

참가 물질

6

반응물 4

HCID 8068N-Methylbutylamine2회HCID 8083MorpholineHCID 21913131HCID 21913131, 화합물HCID 21913486HCID 21913486, 화합물

생성물 1

HCID 21913048HCID 21913048, 화합물수율 76.8%

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

The general methods described in Example 101 were used with the following modifications. To one-third of the crude solution of 4-[3-(5,6-dimethyl-8-propyl-7H-imidazo[4,5-c]tetrazolo[1,5-a]pyridin-7-yl)propane-1-sulfonyl]benzoyl chloride in dichloromethane, described in Part B of Example 101, was added N-methyl butylamine (0.583 mL, 4.92 mmol) in lieu of morpholine, and the reaction was stirred overnight. Additional N-methyl butylamine (0.5 mL) was added, and the reaction was stirred for two hours. The crude product was recrystallized from ethyl acetate:hexane, and the crystals were dried for three hours in a vacuum oven at 90° C. N-Butyl-4-[3-(5,6-dimethyl-8-propyl-7H-imidazo[4,5-c]tetrazolo[1,5-a]pyridin-7-yl)propane-1-sulfonyl]N-methyl benzamide (770 mg, 1.46 mmol) was treated as described in Part C of Example 101. The crude product was recrystallized from ethyl acetate:hexane with a couple drops of methanol to provide crystals, which were isolated by filtration, washed with hexane, and dried for four hours under high vacuum at 50° C. to provide 0.56 g of 4-[3-(4-amino-6,7-dimethyl-2-propyl-1H-imidazo[4,5-c]pyridin-1-yl)propane-1-sulfonyl]-N-butyl-N-methylbenzamide as a white powder, mp 127.0–129.0° C. 1H NMR (300 MHz, CDCl3) δ 7.95 (d, J=8.4, 2H), 7.58 (d, J=8.4, 2H), 4.92 (br s, 2H), 4.42 (dd, J=7.8, 7.8, 2H), 3.55 (dd, J=7.8, 7.8, 1H), 3.21–3.05 (m, 4.5 H), 2.90 (s, 1.5 H), 2.77 (dd, J=7.7, 7.7, 2H), 2.43 (s, 3H), 2.39 (s, 3H), 2.23 (quint, J=7.6, 2H), 1.93–1.36 (m, 5H), 1.15 (quart, J=7.5, 1H), 1.07 (t, J=7.4, 3H), 0.99 (t, J=7.0, 1.5H), 0.81 (t, J=7.4, 1.5H);

후처리

  1. stirringthe reaction was stirred for two hours
  2. customThe crude product was recrystallized from ethyl acetate
  3. dry with materialhexane, and the crystals were dried for three hours in a vacuum oven at 90° C
  4. customThe crude product was recrystallized from ethyl acetate
  5. customhexane with a couple drops of methanol to provide crystals
  6. customwhich were isolated by filtration
  7. washwashed with hexane
  8. customdried for four hours under high vacuum at 50° C.

출처 및 근거

ORD 기록
ord-5df9eeb25e1f4d6f9cd44e3c93567193
출처 데이터셋
uspto-grants-2007_05
특허 번호
US07220758B2

반응 노트

불러오는 중…